Human Genome Epidemiology Literature Finder
|
Records 1 - 9 (of 9 Records) |
| Query Trace: Anemia and CYP2C19[original query] |
|---|
| Valproic acid at therapeutic plasma levels may increase 5-azacytidine efficacy in higher risk myelodysplastic syndromes. Clinical cancer research : an official journal of the American Association for Cancer Research 2009 Aug 15 (15): 5002-7. Voso Maria Teresa, Santini Valeria, Finelli Carlo, Musto Pellegrino, Pogliani Enrico, Angelucci Emanuele, Fioritoni Giuseppe, Alimena Giuliana, Maurillo Luca, Cortelezzi Agostino, Buccisano Francesco, Gobbi Marco, Borin Lorenza, Di Tucci Anna, Zini Gina, Petti Maria Concetta, Martinelli Giovanni, Fabiani Emiliano, Fazi Paola, Vignetti Marco, Piciocchi Alfonso, Liso Vincenzo, Amadori Sergio, Leone Giusep |
| The effect of CYP2C19 polymorphism on the safety, tolerability, and pharmacokinetics of tivantinib (ARQ 197): results from a phase I trial in advanced solid tumors. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2013 Jun 24 (6): 1653-9. Yamamoto N, Murakami H, Nishina T, Hirashima T, Sugio K, Muro K, Takahashi T, Naito T, Yasui H, Akinaga S, Koh Y, Boku |
| A phase I study of tivantinib in combination with temsirolimus in patients with advanced solid tumors. Investigational new drugs 2016 Dec . Kyriakopoulos Christos E, Braden Amy M, Kolesar Jill M, Eickhoff Jens C, Bailey Howard H, Heideman Jennifer, Liu Glenn, Wisinski Kari |
| Pharmacogenetics of toxicity of 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patients. Oncotarget 2018 Feb 9 (10): 9114-9136. Tecza Karolina, Pamula-Pilat Jolanta, Lanuszewska Joanna, Butkiewicz Dorota, Grzybowska E |
| CYP2J27 Genotype Predicts Risk of Chemotherapy-Induced Hematologic Toxicity and Reduced Relative Dose Intensity in Ethiopian Breast Cancer Patients. Frontiers in pharmacology 2019 5 10 481. Ahmed Jemal Hussien, Makonnen Eyasu, Yimer Getnet, Seifu Daniel, Bekele Abebe, Assefa Mathewos, Aseffa Abraham, Howe Rawleigh, Fotoohi Alan, Hassan Moustapha, Aklillu Ele |
| [Not Available]. Kardiologiia 2019 1 58 (12): 22-29. Mansurova J A, Karazhanova L |
| Population pharmacogenomics: an update on ethnogeographic differences and opportunities for precision public health. Human genetics 2021 Oct . Zhou Yitian, Lauschke Volker |
| Association of CYP2C19, CYP2D6 and CYP3A4 Genetic Variants on Primaquine Hemolysis in G6PD-Deficient Patients. Pathogens (Basel, Switzerland) 2023 7 12 (7): . Marielle M Macêdo, Anne C G Almeida, Gabrielly S Silva, Amanda C Oliveira, Victor I Mwangi, Ana C Shuan, Laila R A Barbosa, Fernanda Rodrigues-Soares, Gisely C Me |
| The Effect of CYP2C19*2 (rs4244285) and CYP17 (rs743572) SNPs on Adriamycin and Paclitaxel based Chemotherapy Outcomes in Breast Cancer Patients. Asian Pacific journal of cancer prevention : APJCP 2024 6 25 (6): 1977-1986. Rashmi A Gudur, Suresh J Bhosale, Anand K Gudur, Shivani R Kale, Ashwini L More, Kailas D Datkhi |
- Page last reviewed:Feb 1, 2024
- Content source: